Lobbying Activity Report

1774-49810

Organization: Innovative Medicines Canada (Medicaments novateurs Canada)
Associated registration: 10310-1774-70
Lobbying Activity date: 2026-02-18
Arranged a meeting: No
Posted date: 2026-03-13

In-house lobbyists who participated in the lobbying activity: Charles Brown
Senior Public Office Holders who were lobbied in this activity: Susan Bouma, Executive Director
Therapeutic Assessment & Access, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Sarah Pugh, Executive Director
Health

Ian Rongve, ADM
Ministry of Health, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussion highlighting the contribution of IMC membership to health outcomes and economic sustainability in British Columbia, and advocating for provincial government policy initiatives and investment decisions (e.g., R&D commercialization incentives, infrastructure support) to support the life sciences sector as a driver of long-term economic growth in the province
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Science and Technology
Engage with the BC government to advocate for greater access to innovative medicines and vaccines for British Columbians, supportive policies to attract research and development investment, and greater collaboration to build a stronger life sciences sector and a more sustainable health system.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
 
Senior officer who filed this Lobbying Activity Report: Bettina Hamelin
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: